Literature DB >> 101897

Gamma hydroxybutyrate in the monkey. III. Effect of intravenous anticonvulsant drugs.

O C Snead.   

Abstract

Monkeys were treated intravenously with various anticonvulsant drugs before and after the intravenous administration of gamma hydroxybutyrate (GHB). Continuous electroencephalographic (EEG) and temperature monitoring was performed throughout all experiments. The GHB-induced EEG changes were abolished by ethosuximide and clonazepam, marginally improved by diazepam, and unaffected by phenobarbital. The GHB-induced myoclonic jerks were abolished by ethosuximide, significantly improved by diazepam, and worsened by clonazepam. Phenobarbital was effective in diminishing the frequency of GHB-induced myoclonic jerks only when given prior to administration of GHB. The GHB-induced stupor was improved only by ethosuximide. The GHB model of petit mal seizures is quite specific for drugs used in this disorder. GHB may play a role in the pathogenesis of absence seizures in children.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101897     DOI: 10.1212/wnl.28.11.1173

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  The role of GABAB mechanisms in animal models of absence seizures.

Authors:  S J Caddick; D A Hosford
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

Review 2.  Mechanisms of anticonvulsant drug action. II. Drugs primarily used for absence epilepsy.

Authors:  C L Faingold; R A Browning
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

3.  Electrocorticographic activity induced by gamma hydroxybutyrate in the rat during ontogenesis.

Authors:  R Rokyta; P Mares; P Sobotka
Journal:  Experientia       Date:  1981-07-15

4.  Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.

Authors:  A K Goodwin; P R Brown; E E W Jansen; C Jakobs; K M Gibson; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2009-02-06       Impact factor: 4.530

Review 5.  A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures.

Authors:  Marcello Venzi; Giuseppe Di Giovanni; Vincenzo Crunelli
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243

6.  A pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS-382 in mouse informs novel therapeutic strategies for the treatment of GHB intoxication.

Authors:  Garrett R Ainslie; K Michael Gibson; Kara R Vogel
Journal:  Pharmacol Res Perspect       Date:  2016-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.